We have developed a real-time quantitative polymerase chain reaction (PCR) assay using
TaqMan technology (Applied Biosystems, Foster City, CA) for monitoring donor cell …

Analysis of hematopoietic chimerism after allogeneic stem cell transplantation represents a
crucial method to evaluate donor-cell engraftment. Whereas sensitivity of classical …

We compared the results of chimerism analyses with real‐time SNP‐PCR to those obtained
by the classical STR‐PCR method in 135 hematopoietic stem cell transplantation recipients …

A major end point of nonmyeloablative hematopoietic stem cell transplantation is the
attainment of either mixed chimerism or full donor hematopoiesis. Because the majority of …

Monitoring the engraftment of donor cells after allogeneic blood stem cell transplantation
(BSCT) may be important for the early diagnosis of graft failure or relapse of disease …

Sequential analysis of chimerism after allogeneic blood stem cell transplantation (BSCT)
has been shown to be predictive for graft failure and relapse. We have explored the impact …

The main goal of post-transplantation monitoring in hematopoietic stem cell transplantation
(HSCT) is to predict negative events, such as disease relapse, graft rejection and graft …

Increasing mixed chimerism (MC) after allogeneic stem cell transplantation (SCT) has been
associated with a high risk of relapse in acute leukemia. We evaluated a new method for …

Abstract Analysis of chimerism after allogeneic hematopoietic cell transplantation is
important for assessing engraftment and the early detection of graft failure. In addition, the …

We have studied the feasibility of using DNA restriction fragment-length polymorphisms
(RFLP) to study marrow engraftment in 27 patients after allogeneic bone marrow …